Copaxone and Dupuytren's contracture - a phase IV clinical study of FDA data
Dupuytren's contracture is reported only by a few people who take Copaxone.
The phase IV clinical study analyzes which people take Copaxone and have Dupuytren's contracture. It is created by eHealthMe based on reports of 53,633 people who have side effects while taking Copaxone from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
53,633 people reported to have side effects when taking Copaxone.
Among them, 2 people (0.0%) have Dupuytren's contracture.
What is Copaxone?
Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 52,184 Copaxone users for its effectiveness, alternative drugs and more.
What is Dupuytren's contracture?
Dupuytren's contracture (thickening of the fibrous tissue layer underneath the skin of the palm and fingers) is found to be associated with 445 drugs and 208 conditions by eHealthMe.
Number of Copaxone and Dupuytren's contracture reports submitted per year:
Time on Copaxone when people have Dupuytren's contracture *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 100 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Dupuytren's contracture when taking Copaxone *:
- female: 100 %
- male: 0.0 %
Age of people who have Dupuytren's contracture when taking Copaxone *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common side effects people have besides Dupuytren's contracture *:
- Pain In Extremity: 1 person, 50.00%
- Nodule (a small rock or mineral cluster): 1 person, 50.00%
- Connective Tissue Disorder (any disease that has the connective tissues of the body): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Copaxone and have Dupuytren's contracture?Check whether Dupuytren's contracture is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
How severe was Dupuytren's contracture and when was it recovered:
Expand to all the drugs that have ingredients of glatiramer acetate:
Alternative drugs to, pros and cons of Copaxone:
- Copaxone (52,184 reports)
Common Copaxone side effects:
Browse all side effects of Copaxone:a b c d e f g h i j k l m n o p q r s t u v w x y z
Dupuytren's contracture treatments and more:
- Dupuytren's contracture (2,031 reports)
COVID vaccines that are related to Dupuytren's contracture:
- Dupuytren's contracture in Moderna COVID Vaccine
- Dupuytren's contracture in Pfizer BioNTech Covid Vaccine
- Dupuytren's contracture in Johnson and Johnson Covid Vaccine
Common drugs associated with Dupuytren's contracture:
- Xiaflex: 137 reports
All the drugs that are associated with Dupuytren's contracture:
- Dupuytren's contracture (445 drugs)
Common conditions associated with Dupuytren's contracture:
- Ra: 104 reports
All the conditions that are associated with Dupuytren's contracture:
- Dupuytren's contracture (208 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on glatiramer acetate (the active ingredients of Copaxone) and Copaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Urination - Excessive Volume and Intertrigo - 4 seconds ago
- Triamcinolone and Abelcet drug interaction - 6 seconds ago
- Iressa and Pseudotumor Cerebri - 8 seconds ago
- Permax and Cholestasis - 11 seconds ago
- Neuropathy Peripheral and Weight Decreased - 12 seconds ago
- Kadian and Snoring - 14 seconds ago
- Pantosin and Lymphocyte Count Decreased - 17 seconds ago
- Sumatriptan and Gilenya drug interaction - 17 seconds ago
- Uptravi and Primary Pulmonary Hypertension - 17 seconds ago
- Tacrolimus and Gastrointestinal Inflammation - 29 seconds ago